Treatment of obesity and essential hypertension and related disorders
摘要:
The administration of antagonists and blockers of amylin or CGRP or both for the treatment of obesity and essential hypertension and associated lipid disorders and atherosclerosis.
公开/授权文献
信息查询
0/0